ESCRS is proud to introduce the following smaller companies who will present their emerging technologies at the upcoming iNovation Day on 16 September 2022 in Milan.
Emerging Company Showcases – Onstage Presentations
The following emerging companies will be presenting onstage to talk about their projects and latest technologies.
Allotex: Closing the presbyopia gap with the use of allogeneic corneal tissue
AixLens: Innovative, non-touch manufacturing process for IOLs based on laser technologies
Keranova: Photonic cataract surgery & robotic workflow integration
Fixoflex: A unique ophthalmic implant changing the future of cataract and refractive lens exchange
Ilasis: Femtolaser for cataract surgery
GLASSPOP: Automated subjective refraction
Bynocs: A new-generation, revolutionary cloud-based software for remote management of adult amblyopia
CILIATECH: Cilioscleral interposition device (CID)
BELKIN Vision: Direct selective laser trabeculoplasty
Implandata: Eyemate for continual IOP monitoring and remote glaucoma management
Rowiak: IOL femto-masking – in situ laser generated small aperture to extend depth of focus and reduce photic phenomena
UFONIA: Autonomous telemedicine
Emerging Company Showcases – Roll-up Banners
The following emerging companies will be present in the networking area to talk about their projects and latest technologies.
RADIANCE THERAPEUTICS ADDRESSES THE UNMET NEED IN OCULAR FIBROSIS WITH BETA THERAPY SCAR PROPHYLAXIS IN GLAUCOMA DRAINAGE SURGERIES. RANDOMIZED CONTROLLED TRIALS PROVE SIGNIFICANTLY IMPROVED PATIENT OUTCOMES. LONG-TERM SCAR-FREE BLEBS LEAD TO LOWER IOPS AND SIGNIFICANTLY IMPROVED PATIENT OUTCOMES.
NOVEL NON-INVASIVE & SELF-APPLICABLE PHARMACEUTICAL FORM TO REPLACE EYE DROPS AS WELL AS INTRAOCULAR INJECTIONS : A BIOPOLYMERS-BASED TECHNOLOGY ALLOWING ONE-WEEK CONTROLLED RELEASE OF DRUG THAT IS MORE ACCURATE, EASIER TO USE FOR PATIENTS AND ENABLES A BETTER EFFICACY OF DRUGS
CLINICAL SAFETY AND EFFICACY OF INTRASTROMAL IMPLANTATION OF CORVISION BIOENGINEERED CORNEAL INLAY FOR MANAGEMENT OF PRESBYOPIA
AURION BIOTECH: CELL THERAPY FOR THE TREATEMNT OF CORNEAL EDEMA SECONDARY TO ENDOTHELIAL DYSFUNCTION
EMAGINE: DEMOCRATIZING CORNEAL CROSS-LINKING USING THE SMART WAY
(SAFE, MOBILE, AFFORDABLE, RELIABLE TECHNOLOGY)